A phase I clinical trial of malignant pleural disease treated with regionally delivered autologous mesothelin-targeted CAR T cells: Safety and efficacy Meeting Abstract
| Authors: | Adusumilli, P. S.; Zauderer, M. G.; Rusch, V. W.; O'Cearbhaill, R. E.; Zhu, A.; Ngai, D. A.; McGee, E.; Chintala, N. K.; Messinger, J. C.; Vincent, A.; Halton, E. F.; Diamonte, C.; Pineda, J.; Modi, S.; Solomon, S. B.; Jones, D. R.; Brentjens, R. J.; Rivière, I.; Sadelain, M. |
| Abstract Title: | A phase I clinical trial of malignant pleural disease treated with regionally delivered autologous mesothelin-targeted CAR T cells: Safety and efficacy |
| Meeting Title: | 110th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 79 |
| Issue: | 13 Suppl. |
| Meeting Dates: | 2019 Mar 29-Apr 3 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2019-07-01 |
| Language: | English |
| ACCESSION: | WOS:000488129900031 |
| DOI: | 10.1158/1538-7445.Am2019-ct036 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: CT036 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
